Abiraterone Acetate 43598-0358-31
- Manufacturer
- Dr. Reddys Laboratories Inc
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- May 19, 2020
- Listing Expires
- December 31, 2026
- Application
- ANDA208416
Need to source Abiraterone Acetate? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Abiraterone Acetate | 250 mg/1 |
Drug Class
Cytochrome P450 17A1 Inhibitor [EPC]Cytochrome P450 17A1 Inhibitors [MoA]Cytochrome P450 2C8 Inhibitors [MoA]
Selected Package
43598-0358-31Selected3 BLISTER PACK in 1 CARTON (43598-358-31) / 10 TABLET in 1 BLISTER PACK (43598-358-79)
Other packages for this product(1)
120 TABLET in 1 BOTTLE (43598-358-04)